Trump administration weighs pulling funding for Moderna bird flu vaccine, Bloomberg News reports
U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...
HHS weighs rescinding Moderna bird flu vaccine contract
The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...
Trump Team Weighs Pulling Funds for Moderna Bird Flu Vaccine
US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...
Benzinga on MSN12h
Trump Officials Review Biden-Era Funding For Moderna Bird Flu Vaccine Contract
US health officials are reviewing a nearly $600 million contract awarded to Moderna for bird flu vaccines in the final days ...
New vaccine approved for over-60s - jab uses mRNA technology, just like the Covid shot
The vaccine, manufactured by US pharmaceutical giant Moderna, was found to slash the risk of severe illness from respiratory ...
Distressing Covid vaccine syndrome signs to look out for - could YOU be suffering and not know it?
The previously-unknown condition, dubbed 'post-vaccination syndrome' (PVS), can persist years after taking the Covid vaccines ...
Can Moderna's Aggressive Cost Cuts Help Turn Things Around for Its Stock?
Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future. One way Moderna has been trying to appease investors and reduce its losses ...
Moderna's bird flu vaccine has a problem
A $590 million contract awarded to Moderna by the U.S. government to aid in vaccine development for bird flu is being ...
STAT1d
Pharmalittle: We’re reading about a cancelled FDA vaccine meeting, a Moderna bird flu vaccine, and more
The FDA canceled a vaccine advisory committee meeting to discuss influenza virus strains that should be included in shots for ...
Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV Vaccine
RESVIA® is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) ...
Moderna stock falls amid review of bird flu vaccine funds
Moderna’s reliance on its COVID vaccine for revenue has become a vulnerability as sales decline and the company invests heavily in its product pipeline. The bird flu vaccine contract was expedited due ...